Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 52022SC0191

Initiative summary:
The EU legislation provides high safety and quality standards for blood, tissues and cells. The initiative aims to update the current EU rules for scientific and technological developments, including accommodating innovative therapies. It will also address the (re-)emergence of communicable diseases, including lessons learnt from the COVID-19 pandemic, as well as increasing commercialisation and globalisation of the sector, thereby contributing to a stronger health Union.
EuroVoc thesaurus:
health policy; safety standard; therapeutics; blood transfusion; quality standard; health control; substance of human origin; artificial reproduction; cytology; stem cell